Literature DB >> 23616577

Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.

Andrea Franco1, Bazarragchaa Damdinsuren, Tomoko Ise, Jessica Dement-Brown, Huifang Li, Satoshi Nagata, Mate Tolnay.   

Abstract

Fc receptor-like (FCRL) 5 regulates B cell Ag receptor signaling and has been reported to bind aggregated IgG. Using surface plasmon resonance, we analyzed the interaction of native IgG samples with FCRL5, revealing a complex binding mechanism, where isotype is just one factor. FCRL5 bound IgG1 and IgG4 with ~1 μM KD, whereas the interaction with IgG3 was a magnitude weaker. However, IgG2 samples displayed a wide range of affinities, indicating that additional factors affect binding. We used a panel of 19 anti-FCRL5 mAbs with defined reactivity to identify domains involved in ligand binding. Six mAbs blocked IgG binding, indicating critical roles of FCRL5 domains 1 and 3, as well as epitopes at the domain 1/2 and domain 2/3 boundaries. We found that only glycosylated IgG containing both Fab arms and the Fc region bound with high affinity. Furthermore, the presence of sialic acid in the IgG carbohydrate altered FCRL5 binding. The interaction of IgG and FCRL5 consisted of two kinetic components, suggesting a complex binding mechanism. We established that the IgG-Fc and IgG-F(ab')2 fragments bind FCRL5 independently but with low affinity, revealing the mechanism behind the two-step binding of whole IgG. This complex binding mechanism is distinct from that of Fc receptors, which bind through the Fc. We propose that FCRL5 is a new type of receptor that recognizes intact IgG, possibly enabling B cells to sense Ig quality. Recognition of undamaged IgG molecules by FCRL5 could allow B cells to engage recently produced Abs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23616577      PMCID: PMC3660407          DOI: 10.4049/jimmunol.1202860

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.

Authors:  P Sondermann; R Huber; V Oosthuizen; U Jacob
Journal:  Nature       Date:  2000-07-20       Impact factor: 49.962

2.  The human low affinity Fcgamma receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties.

Authors:  K Maenaka; P A van der Merwe; D I Stuart; E Y Jones; P Sondermann
Journal:  J Biol Chem       Date:  2001-09-05       Impact factor: 5.157

3.  Identification of a family of Fc receptor homologs with preferential B cell expression.

Authors:  R S Davis; Y H Wang; H Kubagawa; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

4.  Contrasting IgG structures reveal extreme asymmetry and flexibility.

Authors:  Erica Ollmann Saphire; Robyn L Stanfield; M D Max Crispin; Paul W H I Parren; Pauline M Rudd; Raymond A Dwek; Dennis R Burton; Ian A Wilson
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

5.  FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma.

Authors:  Kristi Elkins; Bing Zheng; Maryann Go; Dionysos Slaga; Changchun Du; Suzie J Scales; Shang-Fan Yu; Jacqueline McBride; Ruth de Tute; Andy Rawstron; Andrew S Jack; Allen Ebens; Andrew G Polson
Journal:  Mol Cancer Ther       Date:  2012-07-17       Impact factor: 6.261

6.  Human IgG2 can form covalent dimers.

Authors:  Esther M Yoo; Letitia A Wims; Lisa A Chan; Sherie L Morrison
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

7.  IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy.

Authors:  G Hatzivassiliou; I Miller; J Takizawa; N Palanisamy; P H Rao; S Iida; S Tagawa; M Taniwaki; J Russo; A Neri; G Cattoretti; R Clynes; C Mendelsohn; R S Chaganti; R Dalla-Favera
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

8.  Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding.

Authors:  Y Mimura; P Sondermann; R Ghirlando; J Lund; S P Young; M Goodall; R Jefferis
Journal:  J Biol Chem       Date:  2001-09-20       Impact factor: 5.157

9.  DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins.

Authors:  Satoshi Nagata; Giuliana Salvatore; Ira Pastan
Journal:  J Immunol Methods       Date:  2003-09       Impact factor: 2.303

10.  SPAP2, an Ig family receptor containing both ITIMs and ITAMs.

Authors:  Ming-jiang Xu; Runxiang Zhao; Hongxi Cao; Zhizhuang Joe Zhao
Journal:  Biochem Biophys Res Commun       Date:  2002-05-10       Impact factor: 3.575

View more
  27 in total

Review 1.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

2.  CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

Authors:  Benjamin Terrier; Satoshi Nagata; Tomoko Ise; Michelle Rosenzwajg; Ira Pastan; David Klatzmann; David Saadoun; Patrice Cacoub
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

3.  Highly parallel characterization of IgG Fc binding interactions.

Authors:  Austin W Boesch; Eric P Brown; Hao D Cheng; Maame Ofua Ofori; Erica Normandin; Peter A Nigrovic; Galit Alter; Margaret E Ackerman
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

4.  High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis.

Authors:  Hao D Cheng; Henning Stöckmann; Barbara Adamczyk; Ciara A McManus; Altan Ercan; Ingrid A Holm; Pauline M Rudd; Margaret E Ackerman; Peter A Nigrovic
Journal:  Glycobiology       Date:  2017-12-01       Impact factor: 4.313

Review 5.  Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.

Authors:  Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

6.  FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure.

Authors:  Richard T Sullivan; Charles C Kim; Mary F Fontana; Margaret E Feeney; Prasanna Jagannathan; Michelle J Boyle; Chris J Drakeley; Isaac Ssewanyana; Felistas Nankya; Harriet Mayanja-Kizza; Grant Dorsey; Bryan Greenhouse
Journal:  PLoS Pathog       Date:  2015-05-19       Impact factor: 6.823

7.  Characterization of heme binding to recombinant α1-microglobulin.

Authors:  Elena Karnaukhova; Sigurbjörg Rutardottir; Mohsen Rajabi; Lena Wester Rosenlöf; Abdu I Alayash; Bo Åkerström
Journal:  Front Physiol       Date:  2014-12-04       Impact factor: 4.566

8.  A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action.

Authors:  Nishant Mohan; Xiao Luo; Yi Shen; Zachary Olson; Atul Agrawal; Yukinori Endo; David S Rotstein; Lorraine C Pelosof; Wen Jin Wu
Journal:  Cancers (Basel)       Date:  2021-03-01       Impact factor: 6.639

Review 9.  Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies.

Authors:  Caitlin Gillis; Aurélie Gouel-Chéron; Friederike Jönsson; Pierre Bruhns
Journal:  Front Immunol       Date:  2014-05-30       Impact factor: 7.561

10.  Fc receptors for immunoglobulins and their appearance during vertebrate evolution.

Authors:  Srinivas Akula; Sayran Mohammadamin; Lars Hellman
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.